GLOBAL ONCOLOGY CLINICAL Drug Intelligence
This Intelligence Report is designed to Identify Oncology Clinical Stage Drug Developer’s Drug Pipeline, Technologies, Management Expertise, Funding and Partnering capabilities. It clearly demark individual company’s clinical pipeline and its emerging early stage oncology research pipeline.
Report clearly outlines Top Pharma Companie’s Oncology Pipeline with their emerging partnering preferences and inclination towards particular technology domain. Similarly figure out largest number of active mid and small size innovation driven pharma companies, thus provides clear and many uncharted M&A target companies/molecules landscape.
At par with US and Europe, the Report covers largest number of active companies from Chinese & South Korea Region, thus provide an update on the emergence of this region in Oncology Drug Discovery.
providing intelligence at fingertips
Worldwide 33 Countries Covered. Largest Coverage Guaranteed
1009 Active Clinical Stage Oncology Companies Profiled.
Individual Drug Mechanism of Action & Drug Target
Covers complete Emerging Cancer Drug Targets Details with Numerous Technologies
1400+ pages - full of insights
identify Emerging Technologies and Molecules
BETTER THAN OTHERS
Comparisons | Clinical Oncology Drug Intelligence 2022 | Other Intelligence Sources |
|---|---|---|
Clinical Stage Oncology Drug Developers | 1150 Active Companies (Well Funded with complete Oncology Pipeline) | 600-800 Companies (with many inactive and other domain companies) |
Worldwide Coverage | 33 Countries Included (53% USA, 28% Europe, 14% Asia and 5% ROW) | Mainly United States and Europe Covered |
Oncology Drugs in Development | 2800+ Onco Targeting Drugs in Active Development(Clinical & Preclinical Drugs, with their Targets and mechanism of Action) | 250 – 400 Onco Early Stage Drugs (mainly includes Clinical Stage molecules in development) |
Bio-Partnering Details | 1000+ Oncology Deals, with complete details.(Complete coverage on Oncology focused Deals, Funding & Partnering Activities; since company’s incorporation) | Limited to Database / Resource Subscribed to.(Also it may require mapping of events between two or more different resources and filtering Onco Linked Deals). |
Single Step Connect | Over 2500+ Key Decision Makers in 1150 Companieswith valid emails and LinkedIn Accounts Links for one click contact. (Further CRMS Development Support is also available) | No Customized Solution Available in Market(Needs months of hard team work to prepare authentic business development tool. |
